세계의 뇌 모니터링 시장 : 제품 유형, 질병 유형, 절차, 최종 사용자별 예측(2025-2030년)

The Brain Monitoring Market was valued at USD 4.64 billion in 2023, expected to reach USD 4.90 billion in 2024, and is projected to grow at a CAGR of 5.64%, to USD 6.82 billion by 2030.

Brain monitoring technologies encompass a wide range of devices and modalities designed to monitor and assess neurological and physiological states in various settings. This field is crucial for diagnosing and managing conditions such as epilepsy, sleep disorders, traumatic brain injuries, and neurodegenerative diseases. It has critical applications in medical and research environments, including hospitals, clinics, and neurological research centers. The demand for brain monitoring devices is primarily driven by the increasing incidence of neurological disorders and the growing aging population worldwide. Advancements in brain-computer interface technologies and the integration of AI and machine learning in brain monitoring tools are presenting opportunities for innovation, with potential applications in personalized healthcare and neuroprosthetics. Furthermore, the rise of non-invasive techniques coupled with the development of portable and wearable devices is expanding the market's reach, offering convenience and accessibility to patients and researchers alike.

Despite the growth momentum, the market faces several challenges, including high development costs and stringent regulatory requirements that can impede new product launches. Technical limitations, such as the need for precise calibration and potential discomfort for the user, also pose barriers to widespread adoption. To overcome these challenges, ongoing research is crucial, particularly in improving signal accuracy and enhancing user experience. Innovators could focus on developing multi-modal monitoring systems that combine electroencephalography (EEG) with other modalities like near-infrared spectroscopy (NIRS) for comprehensive data collection and analysis. Additionally, partnerships between technology firms and medical institutions can facilitate the development of innovative solutions tailored to specific medical needs. The nature of the market is highly dynamic, with rapid technological advancements shaping its trajectory. Companies seeking growth should invest in collaborative research and stay attuned to regulatory changes while focusing on creating versatile, user-friendly products that address existing pain points.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brain Monitoring Market

The Brain Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidences of neurological diseases and disorders across the world
  • Government initiatives to expand access to neurological healthcare services
  • Preference for personalized digital healthcare solutions and tools
• Market Restraints
  • Technical limitations of brain monitoring solutions
• Market Opportunities
  • Ongoing advancements to improve the efficiency and performance of brain monitoring devices
  • Regulatory approvals and clinical studies for brain monitoring devices and solutions
• Market Challenges
  • Operational complexities of brain monitoring and lack of skilled personnel

Porter's Five Forces: A Strategic Tool for Navigating the Brain Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brain Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brain Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brain Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brain Monitoring Market

A detailed market share analysis in the Brain Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brain Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brain Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brain Monitoring Market

A strategic analysis of the Brain Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Monitoring Market, highlighting leading vendors and their innovative profiles. These include Advanced Brain Monitoring, Inc., ANT Neuro, Bittium, Cerenion Oy, Ceribell, Inc., Compumedics, Ltd., CortiCare, Inc., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, EMOTIV, GE Healthcare, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Myelin-H, Natus Medical, Inc., Neuroelectrics, Neurosteer Inc., NeuroWave Systems Inc., Nihon Kohden Corporation, Rimed Inc., Siemens Healthineers AG, Soterix Medical Inc., Spiegelberg GmbH & Co. KG, and Tristan Technologies, Inc..

Market Segmentation & Coverage

This research report categorizes the Brain Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories and Devices. The Accessories is further studied across Batteries, Cables, Caps, Electrodes, Pastes & Gels, and Sensors. The Devices is further studied across Cerebral Oximeters, CT Scanners, Electroencephalography Devices, Electromyography Devices, Intracranial Pressure Monitors, MEG Devices, MRI Scanners, PET Scanners, Sleep Monitoring Devices, and TCD Devices.
• Based on Disease Type, market is studied across Dementia, Epilepsy, Headache Disorders, Huntington's Disease, Parkinson's Disease, Sleep Disorders, Stroke, and Traumatic Brain Injuries.
• Based on Procedure, market is studied across Invasive and Non-invasive.
• Based on End-User, market is studied across Ambulances, Clinics & Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Neurology Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of neurological diseases and disorders across the world
    • 5.1.1.2. Government initiatives to expand access to neurological healthcare services
    • 5.1.1.3. Preference for personalized digital healthcare solutions and tools
  • 5.1.2. Restraints
    • 5.1.2.1. Technical limitations of brain monitoring solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements to improve the efficiency and performance of brain monitoring devices
    • 5.1.3.2. Regulatory approvals and clinical studies for brain monitoring devices and solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Operational complexities of brain monitoring and lack of skilled personnel
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Need of advanced and specialized devices in the comprehensive monitoring and assessment of brain functions and abnormalities
  • 5.2.2. Disease Type: Brain monitoring is vital for examining disease progression and evaluating treatment efficacy for critical diagnostic insights
  • 5.2.3. Procedures: Advancement in the non-invasive approaches are fundamental in diagnosing and treating various neurological conditions
  • 5.2.4. End-user: Hospitals represent a blend of brain monitoring needs, requiring robustness and versatility to address a range of situations from acute to chronic
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Brain Monitoring Market, by Product

• 6.1. Introduction
• 6.2. Accessories
  • 6.2.1. Batteries
  • 6.2.2. Cables
  • 6.2.3. Caps
  • 6.2.4. Electrodes
  • 6.2.5. Pastes & Gels
  • 6.2.6. Sensors
• 6.3. Devices
  • 6.3.1. Cerebral Oximeters
  • 6.3.2. CT Scanners
  • 6.3.3. Electroencephalography Devices
  • 6.3.4. Electromyography Devices
  • 6.3.5. Intracranial Pressure Monitors
  • 6.3.6. MEG Devices
  • 6.3.7. MRI Scanners
  • 6.3.8. PET Scanners
  • 6.3.9. Sleep Monitoring Devices
  • 6.3.10. TCD Devices

7. Brain Monitoring Market, by Disease Type

• 7.1. Introduction
• 7.2. Dementia
• 7.3. Epilepsy
• 7.4. Headache Disorders
• 7.5. Huntington's Disease
• 7.6. Parkinson's Disease
• 7.7. Sleep Disorders
• 7.8. Stroke
• 7.9. Traumatic Brain Injuries

8. Brain Monitoring Market, by Procedure

• 8.1. Introduction
• 8.2. Invasive
• 8.3. Non-invasive

9. Brain Monitoring Market, by End-User

• 9.1. Introduction
• 9.2. Ambulances
• 9.3. Clinics & Ambulatory Surgical Centers
• 9.4. Diagnostic Centers
• 9.5. Hospitals
• 9.6. Neurology Centers

10. Americas Brain Monitoring Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Brain Monitoring Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Brain Monitoring Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. U College Cork Start-up Raises Euro 2.1 Million to Commercialize AI-enabled Brain Monitor To Detect Seizures In Newborns
  • 13.3.2. Advanced Brain Monitoring, Inc. Announces Integration Of Its Mobile, Wireless 24-channel EEG System with the Stratus EEG Cloud-Based Software for Seizure and Epilepsy Monitoring
  • 13.3.3. Ceribell Launches ClarityPro AI, Expanding Access to Critical Diagnosis of Electrographic Status Epilepticus
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Brain Monitoring, Inc.
• 2. ANT Neuro
• 3. Bittium
• 4. Cerenion Oy
• 5. Ceribell, Inc.
• 6. Compumedics, Ltd.
• 7. CortiCare, Inc.
• 8. Dragerwerk AG & Co. KGaA
• 9. Edwards Lifesciences Corporation
• 10. EMOTIV
• 11. GE Healthcare
• 12. Koninklijke Philips N.V.
• 13. Masimo Corporation
• 14. Medtronic PLC
• 15. Myelin-H
• 16. Natus Medical, Inc.
• 17. Neuroelectrics
• 18. Neurosteer Inc.
• 19. NeuroWave Systems Inc.
• 20. Nihon Kohden Corporation
• 21. Rimed Inc.
• 22. Siemens Healthineers AG
• 23. Soterix Medical Inc.
• 24. Spiegelberg GmbH & Co. KG
• 25. Tristan Technologies, Inc.